[1] |
Li Jinhao, Hu Dongmei, Xu Caihong.
Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407.
|
[2] |
Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu.
Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
|
[3] |
Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong.
Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424.
|
[4] |
An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui.
Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438.
|
[5] |
Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui.
Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453.
|
[6] |
Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi.
Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459.
|
[7] |
Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long.
Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476.
|
[8] |
Hao Mingxiao, Mi Jie, Xu Zongyi.
Effectiveness of a continuity of care model in patients with tuberculous meningitis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481.
|
[9] |
Liu Juxiu, Zhang Jianhua, Wen Junjun, Jiang Xiaoshuang.
Analysis and trend prediction of Mycobacterium tuberculosis drug resistance in Jilin City
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 348-354.
|
[10] |
Huang Misun, Wu Yaning, Li Guilian, Liu Haican.
Research advances of Mycobacterium tuberculosis enrichment technology
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373.
|
[11] |
Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao.
Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163.
|
[12] |
Xue Yu, Yang Xinting, Wang Guirong, Liu Fangchao, Lei Xuan, Zhang Jing, Li Liang.
Analysis of risk factors for death in emergency pulmonary tuberculosis patients and risk model construction
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 189-194.
|
[13] |
Wang Dafu, Ma Xiaoxue, Wang Yun, Li Fudong, Rao Wen, Gong Tingting, Li Shijun, Li Jinlan.
Analysis of risk factors for patient delay and adverse treatment outcomes among patients with pulmonary tuberculosis and diabetes mellitus in Guizhou Province, 2016—2023
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 201-209.
|
[14] |
Liu Ruihua, Sarina , Wang Furong.
Interaction between lung cancer and tuberculosis in disease development and progression
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 102-111.
|
[15] |
Liang Linlong, Pei Yi, Zhou Haiyi, Xie Qifang, Zhang Feng, Jiang Jie, Liu Fuqiang.
The epidemiological characteristics and trends of tuberculosis among children aged 0-14 years in Hunan Province from 2014 to 2023
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 29-35.
|